Rafael Pharmaceuticals Inc. Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Newark NJ United States (2000)

Organization Overview

First Clinical Trial
2008
NCT00741403
First Marketed Drug
2004
propoxyphene (Darvon)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CORNERSTONE | Cornerstone Pharmaceuticals, Inc. | Rafael Pharmaceuticals Inc.